Jeff Aronin is not only a CEO of a major company he is also considered a philanthropist as well. As the CEO of Paragon Biosciences, Jeff strives to not only help build successful Biotech companies but do so in a manner that puts patients first.
The main focus of Jeff Aronin’s company is to help facilitate the development of treatments for patients suffering from rare diseases who have little to no treatment options available. In order for a healthcare startup to become successful and self-sustaining, they need to be financially sound and have the knowledge and resources to turn to during the early years of research and development. Paragon Biosciences and it’s CEO, Jeff Aronin, have a business model that has led them to experience great success incubating successful and innovative companies. They offer both financial and strategic assistance to biotechnology companies that are striving to create new medicines. By supporting these companies, Jeff and Paragon aid in the development of these new medicines that will benefit those patients who have nowhere else to seek help.
Perhaps one of the most influential reasons behind why his company, Paragon Biosciences, is so successful, is because Jeff is well known in the biotech community as a compassionate leader with a heart for serving others. This trait is what allows him to be a pioneer in his industry in not only creating the needed resources to suffering patients, but also to actually care about their well being. Jeff Aronin, Paragon Biosciences and it’s portfolio company’s share a common goal in striving to solve some of healthcare’s most complex problems.
In the current world that we are living in, diseases seem to be more and more prevalent. It is important more now than ever, that we have more CEO’s like Jeff Aronin, who care about the success of their company as well as the well being and quality of life of the patients they are serving.